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The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro
indicator of their marrow-repopulating ability
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In liquid cultures of murine bone marrow cells stimulated with
interleukin-3 and granulocyte/macrophage colony-stimulating
factor, hypoxia (1% oxygen) induced a reversible block of hem-
atopoiesis, maintaining the progenitors’ expansion potential
unreduced. Progenitors repopulating day-14 hypoxic cultures
with cells or granulocyte/macrophage colony-forming units
(CFU-GM) were found, on the basis of their maintenance in
hypoxia (12% and 76%, respectively), to belong to different sub-
sets, the latter being much more efficiently maintained. The
maintenance in hypoxic cultures of progenitors detectable by
marrow-repopulating ability (MRA) assay was 18% for MRAcell
progenitors and 69% for MRACFU progenitors. Thus, the repopu-
lation of hypoxic cultures with cells or CFU-GM closely
reflected the presence of progenitors capable of repopulating,
with cells or CFU-GM, the bone marrow of lethally irradiated
syngeneic animals. Progenitors repopulating hypoxic cultures
were, like MRA progenitors, significantly resistant to 5-
fluorouracil, progenitors repopulating cultures with CFU-GM
being two-fold more resistant than those repopulating cultures
with cells. We concluded that the repopulation of day-14
hypoxic cultures occurring after their transfer to air is to be
considered an indicator of the maintenance of MRA progenitors
in hypoxia. The relevance of these results to stem cell biology
and their potential practical applications are discussed. Leuke-
mia (2000) 14, 735–739.
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Introduction
We previously reported that hematopoietic progenitors from
murine bone marrow (BM) or human cord blood are variously
sensitive to the incubation at low oxygen (1%) tension,1,2 in
a liquid culture system initially designed by Sumner et al3 and
later developed in our laboratory and by others.4,5 We found
that the more primitive the progenitors, the lower their sensi-
tivity to low oxygen, so that incubation in hypoxia selectively
concentrates more immature progenitors. In particular, pro-
genitors detected by a marrow repopulating ability (MRA)
assay based on the count of granulocyte–macrophage colony-
forming units (CFU-GM) in the recipients’ BM (MRACFU
progenitors) were better maintained at low than at normal
oxygen (18–20%). A normal oxygen tension, on the contrary,
was necessary for the generation of CFU-GM in vitro and the
overall numerical expansion of cultures, whereas progenitors
more primitive than CFU-GM and less primitive than MRACFU
progenitors exhibited intermediate degrees of sensitivity to
hypoxia. These results well supported the findings previously
obtained in vivo that: (1) in murine BM, hematopoietic pro-
genitors are distributed along the oxygen gradient, MRA pro-
genitors being more concentrated where oxygen tension is
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lower while CFU-GM reside preferentially in the best-oxygen-
ated subendosteal areas, and (2) the probability of progenitors
to be recruited into the mitotic cycle is inversely related to
their distance from those areas.6–8
In the experiments reported in this paper, liquid cultures
of murine BM cells (BMC) supplemented with granulocyte/
macrophage colony-stimulating factor (GM-CSF) and interleu-
kin-3 (IL3) were used to: (1) determine whether the inhibition
of hematopoiesis in hypoxia is reversible; (2) characterize the
hypoxia-maintained progenitors on the basis of their in vitro
expansion potential, as measured by transferring hypoxic cul-
tures to air; (3) compare these progenitors with progenitors
detectable by the MRA assays. The results indicated that the
hypoxia-dependent block of the expansion of hematopoietic
clones is reversible. Taking advantage of this reversibility, two
types of culture-repopulating progenitors were identified mea-
suring the generation of CFU-GM in vitro and the overall
numerical expansion of cultures. The maintenance of these
progenitors in hypoxia closely paralleled that of two subsets
of MRA progenitors. The progenitors of CFU-GM, like MRACFU
progenitors, exhibited a significantly higher maintenance in
hypoxia and resistance to 5-fluorouracil (5FU). These results
point to the repopulation of hypoxic cultures after their trans-
fer to air as an in vitro indicator of MRA. The potential practi-
cal applications of these findings in studies of normal and
neoplastic hematopoiesis are discussed.
Materials and methods
Cell recovery
Femoral BMC from 8- to 12-week-old CBA mice were flushed
and pooled in RPMI-1640 medium (HyClone Europe, Cram-
lington, UK). Cells were then centrifuged (250 g for 10 min),
resuspended in 0.87% NH4Cl in H2O to lyse erythrocytes,
washed and plated in cell culture dishes, in RPMI-1640 sup-
plemented with 10% heat-inactivated horse serum (HS;
HyClone). After a 3 h incubation, nonadherent cells were
recovered, counted and plated. Cell counts were carried out
in a hemocytometer and cell viability estimated by the trypan
blue exclusion test, diluting cell suspensions 1:1 with a 0.4%
wt/v trypan solution in 0.87% saline.
Liquid cultures
BMC were cultured in RPMI-1640 supplemented with 20%
HS, 5 ng/ml recombinant murine GM-CSF (PeproTech EC,
London, UK) and 20 ng/ml recombinant murine IL3
(PeproTech). Cells were plated at 5 · 106 cells in 5 ml per
flask (see below) and incubated at 37 ° C in water-saturated
atmosphere, as described.1 Incubation at low oxygen tension
was carried out in gas-tight 250 ml glass flasks containing an
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atmosphere composed of 1% O2, 5% CO2, 94% nitrogen
(‘hypoxic cultures’). Control cultures at normal oxygen tension
(‘cultures in air’) were established in similar flasks incubated
in a 95% air, 5% CO2 atmosphere. The pH of the hypoxic
cultures remained within physiological limits (7.2–7.4)
throughout the incubation.
In other experiments, cells directly recovered from animals,
or pre-incubated for 14 days in hypoxia, were treated for 2
days in air or in hypoxia, respectively, with 100 mg/ml 5FU
(Roche, Neuilly-sur-Seine, France), washed twice to remove
5FU, and finally incubated in air for a further 7 days. In some
cases, a-tocopherol (Sigma-Aldrich, Milan, Italy) was added
to cultures at a 10 mM final concentration, to prevent cellular
reoxygenation damage.
Semisolid cultures
To determine the number of granulocyte–macrophage colony-
forming units (CFU-GM) in BMC liquid cultures, in vitro
clonal assays were established by transferring cells from these
cultures into a semisolid medium composed of RPMI-1640,
20% HS, 0.3% (wt/v) agar (Bacto Agar; Difco, Detroit, MI,
USA), 5 ng/ml GM-CSF and 20 ng/ml IL3. Cells were plated
at 104 viable cells/1 ml/dish in quadruplicate 3 cm petri dis-
hes, always incubated in air. After 7 days, the number of col-
onies (aggregates of 50 or more cells) per dish was scored at
a 25· magnification.
MRA assay
The MRA of liquid cultures was measured as described.1 In
brief, CBA mice (8- to 12-week-old) were lethally irradiated
with one dose of 10 Gy, at a rate of 1 Gy/min, from a 60Co,
1.2 MeV source (Theratron 780; Atomic Energy of Canada,
Ottawa, Canada). Cells recovered directly from donor animals
or from day-14 cultures incubated in hypoxia were suspended
in 0.2 ml of serum-free medium and transplanted (1 · 105
cells) into six irradiated recipients per experimental condition.
At day 14 after transplantation, femural nucleated cells were
individually counted, pooled and processed for CFU-GM
assays as described above. MRA of cultures was calculated by
the product of (1) the ratio of total cell number in culture to
the number of transplanted cells with (2) the number of cells
(MRAcell) or of CFU-GM (MRACFU) recovered per recipient’s
femur.
Results
In order to determine whether the inhibition in hypoxia (1%
O2) of the expansion of hematopoietic clones is reversible,
murine BMC were incubated in hypoxia or in air from time-
zero, or in hypoxia and then in air (Figure 1). In control cul-
tures (in air from time-zero), total cell number underwent a
six-fold increase over the first 6 days of incubation, and then
decreased progressively to approach zero in about 4 weeks.
By contrast, in hypoxic cultures, total cell number decreased
from the beginning of incubation to approach zero in about
1 week. When these cultures were transferred to air (at day 7
or day 14), total cell number increased by six or 7.5 times,
respectively, with respect to the values at the time of transfer.
However, the peak of total cell number reached by cultures
reoxygenated at day 14 was significantly lower than that of
Figure 1 Effects of hypoxia on total cell number in liquid cultures
of murine BMC. Cells were incubated in hypoxia (1% O2) or in air
(20% O2) directly after recovery from animals (solid lines), or in
hypoxia for 7 or 14 days and then in air (dashed lines). Points are
means – s.e.m. of five independent experiments (some error bars are
concealed by the symbols). (l) Air from time-zero; (K) hypoxia from
time-zero; (G) hypoxia from time-zero, transfer to air at day 7; (r)
hypoxia from time-zero, transfer to air at day 14.
cultures reoxygenated at day 7, this being lower than that of
control cultures incubated in air from time-zero.
The time-course of CFU-GM in culture is shown in Figure
2. In control cultures incubated in air from time-zero, the
number of CFU-GM increased by 2.5 times over the first 6
days, and then decreased progressively to approach zero in
about 2 weeks. In hypoxic cultures, the number of CFU-GM
started to decrease immediately after the beginning of incu-
bation, to approach zero in about 1 week. The transfer at day
14 of hypoxic cultures to air and their further incubation for
9 days resulted in a six-fold increase of the number of CFU-
Figure 2 Effects of hypoxia on the time-course of CFU-GM in
liquid cultures of murine BMC. Cells were incubated in hypoxia or
in air directly after recovery from animals (solid lines), or in hypoxia
for 14 days and then in air (dashed line). At selected incubation times
cells were replated in semisolid medium and CFU-GM-derived colon-
ies counted 7 days later. Points are means – s.e.m. of five independent
experiments (some error bars are concealed by the symbols). (l) Air
from time-zero; (K) hypoxia from time-zero; (R) hypoxia from time-
zero, transfer to air at day 14.
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GM over the value at the time of transfer. This reversibility
of the inhibition of the hematopoietic expansion occurring in
hypoxia was not enhanced by the complete renewal of culture
medium or the addition of antioxidants, such as a-tocopherol,
to prevent cellular reoxygenation damage (not shown).
The data shown in Figures 1 and 2 were computed in Table
1 to quantify, and compare with each other, the potentials of
hypoxia-maintained cells for culture repopulation with cells
or CFU-GM. Lines A and B indicate that after 14 days of incu-
bation in hypoxia the maintenance of time-zero ability of
repopulating cultures with cells was 12% and that with CFU-
GM 76%. Table 1 also shows (lines C and D) that in cultures
incubated in hypoxia for 14 days MRAcell was 18% of the
time-zero value, and MRACFU 69%. These values were very
similar to those of lines A and B, ie the maintenance in
hypoxia of progenitors capable of repopulating, with cells or
CFU-GM, the aplastic BM of lethally irradiated animals
closely matched the maintenance of progenitors capable of
repopulating, with cells or CFU-GM, hypoxic cultures after
their transfer to air.
MRA progenitors are relatively resistant to cell cycle-spe-
cific cytotoxic drugs such as 5FU.9 In order to assess whether
culture-repopulating progenitors in our system are also 5FU-
resistant, we determined the effects of 5FU in vitro on the
increase of total cell number and CFU-GM number (Table 2).
Cells directly recovered from animals, or preincubated for 14
days in hypoxia, were treated with 5FU for 2 days in air or
hypoxia, respectively, and then incubated for 7 days after
removal of 5FU, in both cases in air. In cultures treated with
5FU in hypoxia, substantial numbers of cells and CFU-GM
were generated during the following incubation in air (column
2). On the contrary, few viable cells and no CFU-GM were
found in cultures treated with 5FU in air (column 1). Thus,
incubation in hypoxia during the treatment with 5FU was
required for both total cell number and CFU-GM number
increase in air after removal of the drug. This indicates that
Table 1 Maintenance in hypoxia of culture- and marrow-repopul-
ating abilities
Culture 1 2 3
content
6 days in air 14 days in hypoxia Maintenance
+9 days in air in hypoxia
A cells 25.8 – 11.3 · 106 3.2 – 0.2 · 106 0.12
B CFU 20.4 – 7.3 · 103 15.4 – 8.0 · 103 0.76
Time zero 14 days in hypoxia Maintenance
in hypoxia
C MRAcell 12.7 – 4.3 · 106 2.3 – 0.9 · 106 0.18
D MRACFU 14.6 – 3.8 · 103 10.1 – 6.1 · 103 0.69
Lines A and B: column 1 reports the cell or CFU-GM number
increase in cultures incubated in air for 6 days from time-zero (ie
the differences between the peak and time-zero values of Figures
1 and 2); column 2 reports the cell or CFU-GM number increase
in cultures incubated in hypoxia for 14 days from time-zero and
then in air for 9 days (ie the differences of Figures 1 and 2 between
the peak values reached by hypoxic cultures after their transfer to
air and the values at the time of transfer). Lines C and D: the values
are means – s.e.m. of six independent experiments, each carried
out using six mice per incubation time. Values represent the pro-
duct between the number of cells or CFU-GM recovered per recipi-
ent’s femur and the ratio of total cell number in culture at time-zero
(column 1) or after 14 days in hypoxia (column 2) to the number
of transplanted cells (1 · 105 per recipient).
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hypoxia-incubated, but not air-incubated, cultures contained
5FU-resistant progenitors repopulating cultures with cells or
CFU-GM. To estimate the percentage of 5FU-resistant pro-
genitors within the hypoxia-maintained progenitors, the data
of column 2 were compared with those obtained from
hypoxic cultures incubated in the absence of 5FU (column 3).
Column 4 shows that 16% of hypoxia-maintained progenitors
sustaining the increase of total cell number and 32% of those
responsible for the increase of CFU-GM number were 5FU-
resistant. When the data of Tables 1 and 2 were combined
to estimate the absolute percentage of 5FU-resistant hypoxia-
maintained progenitors (Figure 3), it emerged that 24% of pro-
genitors repopulating cultures with CFU-GM were 5FU-resist-
ant, whereas a negligible percentage (,2%) of progenitors
repopulating cultures with cells survived the treatment with
5FU.
Discussion
The first advancement we obtained from this work with
respect to our previous study1 was that the hypoxia-induced
block of the expansion of hematopoietic clones is reversible
(Figure 1). In hypoxic cultures, indeed, total cell number
increase with respect to the time of transfer to air (at days 7
or 14; six- or 7.5-fold, respectively) was identical to that of
controls with respect to time-zero (six-fold). However, as the
longer the incubation in hypoxia, the lower the peak values
of total cell number, we concluded that hypoxia determined
a progressive loss of hematopoietic clones, yet combined with
an unreduced expansion potential of hypoxia-maintained
clones. This implies that the counts obtained from hypoxic
cultures following their transfer to air reflect the number of
progenitors whose expansion potential is preserved. When
this conclusion was applied to the comparison of data of Fig-
ures 1 and 2, progenitors responsible for CFU-GM generation
resulted more efficiently maintained in hypoxia than those
sustaining total cell number increase. As the difference was
marked (6.3 times, as calculated from column 3 of Table 1),
the two types of progenitors clearly belong to different subsets,
a conclusion in keeping with the previous finding that mainte-
nance in hypoxia is a distinctive property of hematopoietic
progenitors.1
To characterize the two subsets of culture-repopulating pro-
genitors identified via the reversibility of the effect of hypoxia,
their maintenance in hypoxic cultures was compared with that
of MRA progenitors, which are selectively enriched and well
maintained in hypoxia.1 In day-14 hypoxic cultures, MRACFU
and MRAcell resulted in 69% and 18% of the time-zero value,
respectively (Table 1). These figures closely match those pre-
viously obtained1 for day-5 hypoxic cultures (73% for MRACFU
and 23% for MRAcell) stimulated with a spleen conditioned
medium providing conditions rather similar to the combi-
nation of IL3/GM-CSF used in this study. This indicates that
the extension of the incubation in hypoxia from 5 to 14 days
did not significantly reduce the percentage maintenance in
hypoxia of MRA progenitors, confirming that this maintenance
is a distinctive property of each progenitor subset, rather than
being a function of incubation time. The most interesting
result, however, emerging from the in vivo experiments was
that the percentages of maintenance in hypoxia of MRA were
similar to those of culture-repopulating progenitors (Table 1),
the value obtained for MRACFU progenitors in particular being
very close to that of cells generating CFU-GM in vitro (69%
vs 76%). Thus, the maintenance in hypoxia of progenitors
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Table 2 Effects of 5FU in vitro on progenitors repopulating cultures with cells or CFU-GM
Culture content 1 2 3 4
Time zero 14 days in hypoxia
+5FU
+5FU - 5FU +5FU/- 5FU
Cells 4.0 – 3.0 · 103 180 – 50 · 103 1150 – 260 · 103 0.16
CFU-GM 0 2.6 – 0.8 · 103 8.3 – 2.2 · 103 0.32
Cells directly recovered from animals (time-zero) or incubated for 14 days in hypoxia were treated with 5FU for 2 days in air or hypoxia,
respectively, and then incubated for 7 days in air after removal of 5FU (columns 1 and 2). Cells were incubated in the absence of 5FU
for 16 days in hypoxia and then for 7 days in air (column 3). The number of CFU-GM was determined in secondary clonal assays. Values
are means – s.e.m. of three (columns 1 and 2) or five (column 3) separate experiments. Differences between values of columns 2 and 3
were found statistically significant according to the Student’s t-test (cells: P , 0.02; CFU-GM: P , 0.05).
Figure 3 Maintenance in hypoxia and 5FU-resistance of culture-
repopulating progenitors. The Figure summarizes the results reported
in Tables 1 and 2. The data are expressed as percentages of those
obtained for 5FU-untreated cultures incubated in air for 6 days from
time-zero (as in Table 1, column 1, lines A or B). As for cultures incu-
bated in hypoxia, grey histograms (without 5FU) correspond to the
values of Table 1, column 3, lines A or B, while black histograms
(with 5FU) represent the product of these values by the corresponding
values of Table 2, column 4. CFU-prog, progenitors repopulating cul-
tures with CFU-GM; cell-prog, progenitors repopulating cultures
with cells.
capable of repopulating cultures, with cells or CFU-GM,
closely reflected that of progenitors capable of repopulating,
with cells or CFU-GM, the bone marrow of lethally irradiated
animals. In other words, the two parameters we measured in
day-14 hypoxic cultures after their repopulation in air
appeared suitable as indicators of the maintenance in hypoxia
of two subsets of MRA progenitors.
Strong support of the above conclusion, as well as of the
identification of two different subsets of hypoxia-maintained
culture-repopulating progenitors, came from the experiments
based on 5FU (Table 2). The rationale of these experiments
was that, as MRA progenitors are relatively resistant to cell
cycle-specific cytotoxic drugs such as 5FU,9 to determine the
5FU resistance of culture-repopulating progenitors would help
in pursuing their characterization. In 5FU-treated hypoxic cul-
tures, substantial numbers of cells and CFU-GM were gener-
ated during the following incubation in air, indicating that
sizeable percentages of culture-repopulating progenitors were
5FU-resistant. However, progenitors responsible for CFU-GM
generation were two times more resistant than progenitors sus-
taining total cell number increase, the percent 5FU-resistance
values (32% and 16%, respectively) being comparable to
those obtained by Hodgson and Bradley9 (42% and 23%) for
the survival of MRACFU and MRAcell progenitors after a 24 h
treatment with 5FU in vivo. On the whole, the 5FU experi-
ments indicated that the two subsets of culture-repopulating
progenitors we identified react differently to 5FU and are most
probably related to the two main subsets of MRA progenitors.
The effects of 5FU in vitro on the maintenance of MRA pro-
genitors could not be directly determined in our system, as
even large hypoxic cultures were unable to support survival of
lethally irradiated mice. The early death of transplanted mice
suggested that this was most probably due to the insufficient
content of late hematopoietic progenitors and maturing pre-
cursors, highly sensitive to 5FU, rather than to an insufficient
MRA, which, inferring from Table 2 by comparison with cul-
ture-repopulating progenitors, was reduced to 16–32%. The
demonstration of a significant 5FU resistance of hypoxia-
maintained progenitors represents another advancement over
our previous study.1
When the data relative to the maintenance of progenitors
in hypoxia and to their 5FU-resistance were taken together
(Figure 3), the subset of progenitors repopulating cultures with
CFU-GM appeared functionally heterogeneous. Out of four of
these progenitors present in culture at time-zero, indeed, one
was hypoxia-maintained and 5FU-resistant, two were
hypoxia-maintained and 5FU-sensitive, and one was hypoxia-
and 5FU-sensitive. As for the comparison, among hypoxia-
maintained cells, of 5FU-resistant with 5FU-sensitive progeni-
tors, the hypothesis that the former are quiescent, while the
latter are in cycle, is a very straightforward one. This hypoth-
esis is also in keeping with the fact that in air, where all cells
are presumably cycling, no progenitor survived the treatment
with 5FU. Thus, hypoxia appears as a necessary, although not
sufficient, condition for quiescence of short-term repopulating
(STR) cells, such as MRACFU progenitors or progenitors repop-
ulating cultures with CFU-GM. In hypoxia, in other words,
STR progenitors would be able to remain in a quiescent state,
yet being recruitable to commitment and clonal expansion.10,11
On this basis, the 5FU experiments reported here provide
experimental support to our hypothesis that, in relatively
hypoxic areas of BM, the progenitors’ response to
recruitment/proliferation/differentiation stimuli is modulated in
favor of their maintenance and long-term conservation.1 To
generate lineage-restricted progeny and then undergo extensive
clonal expansion, STR progenitors would be required to move
to areas of BM at higher oxygen tensions, a process mimicked
in our experimental system by culture transfer to air.
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The above scenario is certainly influenced by the available
growth factors. The combination of IL3 and GM-CSF used in
our study supports proliferation of multipotent progenitors12
and survival in culture, as well as ‘proliferation com-
petence’,13 but not cell cycling14–16 of quiescent stem cells.
The latter is, indeed, triggered by ‘proliferation progression’
factors, which include stem cell factor, interleukin-6, interleu-
kin-11, granulocyte colony-stimulating factor, leukemia
inhibitory factor and FLT3-ligand. Therefore, under the con-
ditions described here, only STR progenitors activated in vivo
would be recruitable, but not long-term repopulating (LTR)
quiescent stem cells imported as such to cultures. We are cur-
rently studying, by means of the experimental system
presented here, the effects of ‘proliferation progression’ factors
on LTR progenitors in hypoxia, examining in particular the
possibility that hypoxia favors the generation of STR progeni-
tors in culture.
In conclusion, we showed that incubation at a rather low
oxygen tension (1%) reversibly blocks the expansion of hema-
topoietic clones. The expansion potential of these clones is
unreduced, so that the counts obtained from hypoxic cultures
following their transfer to air reflect the number of hypoxia-
maintained progenitors. A sizeable percentage of these pro-
genitors is 5FU-resistant. The complex of these data represents
a significant advancement over the results of our previous
study.1 Furthermore, two subsets of culture-repopulating pro-
genitors were identified, whose percentages of maintenance
in hypoxia and resistance to 5FU were similar to those of the
two main subsets of MRA progenitors. Thus, the repopulation
of hypoxic cultures after their transfer to air appeared suitable
as an indicator of MRA maintenance in hypoxia. The experi-
mental system described here can be useful, in studies of
murine hematopoiesis, to overcome problems due to the low
probability of survival of animals transplanted with in vitro
manipulated cell populations; in human studies, it is signifi-
cantly easier and more rapid to perform than the long-term
culture-initiating cell assay. We plan to use this system for
the characterization of maintenance in hypoxia, response to
growth factors and sensitivity to cell cycle-specific cytotoxic
drugs, of progenitors from acute or chronic myelogenous
leukemia explants.
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